Latest News and Press Releases
Want to stay updated on the latest news?
-
IXONOS PLC STOCK EXCHANGE RELEASE 13 AUGUST 2008 at 9:30 IXONOS PLC INTERIM REPORT 1 JANUARY - 30 JUNE 2008 CONTINUED TURNOVER GROWTH;...
-
The shareholders in Aker Philadelphia Shipyard ASA are invited to attend an extraordinary General Meeting to be held on Tuesday 2 September 2008 at 10.00 hrs at Felix Conference Centre, Byggetorget 3,...
-
Aksjonærene i Aker Philadelphia Shipyard ASA innkalles til ekstraordinær generalforsamling Tirsdag 2. september 2008 kl. 10.00 på Felix konferansesenter, Bryggetorget 3, Aker Brygge,...
-
DIBS Interim report January - June 2008 Condensed January - June 2008 n Net sales SEK 49,5 M (36,3) + 36% n Operating profit SEK 11.0 M (9.2) + 20% n Profit after tax SEK 11.3 M (9.3) + 22% n Profit...
-
Oslo (2008-08-13): On Tuesday 12 August Svein Flatebø, board member, Yara International ASA, purchased 780 Yara shares at a price of NOK 299 per share. Following this purchase Mr. Flatebø owns 1,291...
-
DELÅRSRAPPORT JANUARI-JUNI 2008 FORTSATT TILLVÄXT • Orderingång: 5.075 MSEK (4.835) • Nettoomsättning: 4.530 MSEK (4.390) • Rörelseresultat: 283 MSEK (192) • Resultat efter skatt: 178 MSEK (117) •...
-
INTERIM REPORT JANUARY - JUNE 2008 CONTINUED GROWTH • Inflow of orders: SEK 5,075 million (4,835) • Net sales: SEK 4,530 million (4,390) • Operating earnings: SEK 283 million (192) • Net earnings:...
-
SAMPO PLC STOCK EXCHANGE RELEASE 13 August 2008, at 9.30am SAMPO GROUP´S RESULTS FOR JANUARY - JUNE 2008 Strong solvency smoothes the...
-
DIBS Delårsrapport januari - juni 2008 Januari - juni 2008 i sammandrag n Nettomsättningen 49,5 Mkr (36,3) + 36 % n Rörelseresultatet 11,0 Mkr (9,2) + 20 % n Resultatet efter skatt 11,3 Mkr (9,3) +...
-
Enclosed please find the Q2 2008 report....
-
Interim Report 1 January - 30 June 2008 • Net sales: SEK 257.7 (224.7) million • Profit after tax: SEK 39.3 (22.5) million • Profit per share after tax: SEK 0.82 (0.47) • EBITDA of USD 11.6 (5.3)...
-
Delårsrapport 1 januari - 30 juni 2008 • Nettoomsättning MSEK 257,7 (224,7) • Resultat efter skatt MSEK 39,3 (22,5) • Resultat efter skatt per aktie SEK 0,82 (0,47) • EBITDA om MUSD 11,6...
-
A clinical study of ALK's tablet vaccine against house dust mite allergy showed an effect that was highly statistically significant and met its primary endpoint. The study showed a 50% reduction in...
-
Ahlstrom Corporation STOCK EXCHANGE RELEASE 13.8.2008 The Board of Directors of Ahlstrom Corporation has appointed M.Sc. (Econ.) Jan Lång President & CEO of the company. He will take over the...
-
Ahlstrom Oyj PÖRSSITIEDOTE 13.8.2008 Ahlstrom Oyj:n hallitus on nimittänyt KTM Jan Långin yhtiön toimitusjohtajaksi. Hän aloittaa uudessa tehtävässään 1.1.2009. Lång (s. 1957) siirtyy...
-
Bayerische Landesbank / Preliminary announcement on the disclosure of financial statements 13.08.2008 Announcement according to articles 37v, 37w, 37x ff....
-
BKN International AG / Contract 13.08.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
UBS AG / Third country release according to Article 30e Para. 1, No. 3 of the WpHG [the German Securities Trading Act] 13.08.2008 Release of a Post-admission Duties announcement according to...
-
Manz Automation AG / Half Year Results 13.08.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
Kemira Group Press release August 13, 2008 at 9.00 am (CET+1) Kemira Oyj is investigating ownership alternatives for its subsidiary Galvatek. Galvatek is specialized in planning and...
-
Kemira Oyj Lehdistötiedote 13.8.2008 klo 9.00 Kemira Oyj on käynnistänyt selvitystyön tytäryhtiönsä Galvatek Oy:n omistusvaihtoehdoista. Pinta- ja vedenkäsittelylaitosten suunnitteluun ja...
-
Highlights of the first half of 2008 - Increase of revenue by more than 6% to EUR 913 million (10% at constant exchange rates) - Organic revenue growth of approximately 3% (at constant...
-
Highlights 1e halfjaar 2008 Stijging netto-omzet ruim 6% tot EUR 913 miljoen (10% tegen constante wisselkoersen) Autonome omzetgroei van circa 3% (tegen constante wisselkoersen) Bedrijfsresultaat...
-
Solteq Plc Stock Exchange Bulletin 13.8.2008 at 9.00am - Turnover increased during the review period by 14,2 % and during the second quarter by 19,5 %. - The operating result for the period...
-
SOLTEQ Oyj Pörssitiedote 13.8.2008 klo 9.00 - Liikevaihto kasvoi katsauskaudella 14,2 prosenttia ja vuoden toisella neljänneksellä 19,5 prosenttia - Liiketulos 0,4 miljoonaa euroa oli...
-
Interim report January-June 2008 Second quarter □ Order intake amounted to SEK 1,686 M (1,688) - up 4% adjusted1 □ Net sales advanced 2% to SEK 1,548 M (1,524) - up 5%, adjusted1 □ Costs for the MEP2...
-
Delårsrapport januari-juni 2008 Andra kvartalet □ Orderingången uppgick till 1 686 Mkr (1 688) - justerad1 upp 4% □ Nettoomsättningen ökade till 1 548 Mkr (1 524), upp 2% - justerad1 upp 5% □...
-
HONKARAKENNE OYJ INTERIM REPORT 13 AUGUST 2008 AT 9:00 AM INTERIM REPORT 1 JANUARY - 30 JUNE 2008 Honkarakenne's consolidated net sales from...
-
Lundbeck har opnået et særdeles godt finansielt resultat for 2. kvartal 2008. Omsætningen fortsætter med at vokse og er i løbet af 2. kvartal 2008 steget med 12% i forhold til samme periode sidste...
-
Lundbeck achieved an exceptionally strong financial performance in Q2 2008 with revenue continuing to grow and climbing 12% on the year-earlier period. Exclusive of a DKK 481 million writedown of...
-
Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the United States. Under the Cooperative Research and...
-
Bavarian Nordics amerikanske datterselskab, BN ImmunoTherapeutics, har indgået et videnskabeligt partnerskab med det internationalt anerkendte National Cancer Institute (NCI) i USA. Som led i en...
-
Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the United States. Under the Cooperative Research...
-
Bavarian Nordics amerikanske datterselskab, BN ImmunoTherapeutics, har indgået et videnskabeligt partnerskab med det internationalt anerkendte National Cancer Institute (NCI) i USA. Som led i en...
-
Stock Exchange release 13 August 2008 9.00 am Uponor's CEO Jan Lång resigns, search for a new CEO started Uponor Corporation's President and CEO Jan Lång has announced his resignation in...
-
SalMar ASA leverer et godt resultat på tross av biologiske utfordringer som påvirker produksjonskostnadene Driftsinntektene for SalMar ASA ble NOK 415 millioner i andre kvartal 2008...
-
SalMar delivers good results despite pressure on production costs SalMar generated gross operating revenues of NOK 415 million in the second quarter 2008, compared with NOK 339 million in...
-
SalMar ASA leverer et godt resultat på tross av biologiske utfordringer som påvirker produksjonskostnadene Driftsinntektene for SalMar ASA ble NOK 415 millioner i andre kvartal 2008...
-
First North meddelelse nr. 61/13. august 2008 Brøndby den 13. august 2008 NanoCover A/S - Konkursbegæring er tilbagetrukket, udsættelse af halvårsmeddelelse samt udmeldt af DITAS sortiment...
-
DIC Asset AG / Interim Report 13.08.2008 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the...
-
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the...
-
Regulated information* - 13 August 2008 (7.30 a.m. CEST) Please be informed that the 1H2008 half-yearly report of KBC Bank (in Dutch) is available on www.kbc.com/investor...
-
Gereglementeerde informatie* - 13 augustus 2008 (7.30 a.m. CEST) Het 1H2008 halfjaarverslag van KBC Bank is beschikbaar op de website www.kbc.com/investor relations/financiële informatie KBC...
-
Tecnomen Corporation INTERIM REPORT 13 August 2008 at 8.30 am TECNOMEN'S INTERIM REPORT 1 JANUARY - 30...
-
For release content, please refer to the attachment....
-
Underlying net profit of EUR 1,946 million, down 28.8% from 2Q07 on lower investment income Net earnings per share down 20.3% to EUR 0.94; EUR 5 billion share buyback added EUR 0.05 per share...
-
STADA Arzneimittel AG / Half Year Results 13.08.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
HOUSTON, Aug. 13, 2008 (PRIME NEWSWIRE) -- Transmeridian Exploration Incorporated (AMEX:TMY) ("Transmeridian") and its wholly-owned subsidiary Transmeridian Exploration Inc. ("TMEI") today announced...
-
Hypo Real Estate Holding AG / Half Year Results 13.08.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...